• Anti-human platelet antigen (HPA)-1a antibodies may affect trophoblast functions crucial for placental development: A laboratory study using an in vitro model 

      Eksteen, Mariana; Heide, Gøril; Tiller, Heidi; Zhou, Yan; Nedberg, Nora Hersoug; Martinez-Zubiaurre, Inigo; Husebekk, Anne; Skogen, Bjørn Ragnar; Stuge, Tor Brynjar; Kjær, Mette (Journal article; Tidsskriftartikkel; Peer reviewed, 2017-04-21)
      Background: Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a bleeding disorder caused by maternal antibodies against paternal human platelet antigens (HPAs) on fetal platelets. Antibodies against HPA-1a are accountable for the majority of FNAIT cases. We have previously shown that high levels of maternal anti-HPA-1a antibodies are associated with clinically significant reduced birth ...
    • Anti-human platelet antigen (HPA)-1a antibodies: For better or for worse 

      Eksteen, Mariana (Doctoral thesis; Doktorgradsavhandling, 2015-12-11)
      Albeit a rare pregnancy complication, fetal and neonatal alloimmune thrombocytopenia (FNAIT) due to anti-human platelet antigen (HPA)-1a antibodies carries a significant risk of intracranial bleeding in the fetus and newborn. Reduced birth weight is another possible complication of FNAIT. Currently, there is no specific treatment to prevent or treat FNAIT, neither exist screening programs identifying ...